Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R6 - Effective April 01, 2023 Apr 20, 2023
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58996) - R3 - Effective February 18, 2022 Mar 30, 2023
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R11 - Effective October 01, 2022 Mar 30, 2023
Billing and Coding: Intraocular Bevacizumab (A53008) - R13 - Effective April 1, 2023 Mar 30, 2023
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) - R12 - Effective April 1, 2023 Mar 30, 2023
Billing and Coding: Lab: Controlled Substance Monitoring and Drugs of Abuse Testing (A55001) - R16 - Effective April 1, 2023 Mar 30, 2023
Provider Notice - Dental Services, March 2023 Mar 03, 2023
Billing and Coding: JW and JZ Modifier Billing Guidelines (A53024) - R6 - Effective January 10, 2023 Mar 02, 2023
Billing and Coding: Complex Drug Administration Coding (A58532) - R12 - Effective January 01, 2023 Mar 02, 2023
Billing and Coding: Routine Dental Services Article Retirement - January 1, 2023 Mar 02, 2023
Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (A57037) - R5 - Effective January 01, 2023 Feb 27, 2023
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R5 - Effective January 01, 2023 Feb 27, 2023
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R10 - Effective January 01, 2023 Feb 24, 2023
Multiple Local Coverage Determinations (LCDs) - Published for Review and Comments Feb 10, 2023
Billing and Coding: Artificial Hearts and Percutaneous Endovascular Cardiac Assist Procedures and Devices (A52966) - R14 - Effective October 1, 2022 Feb 01, 2023
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R3 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57901) - R3 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: MolDX: Know error (A55274) - R3 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58996) - R2 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R5 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: Botulinum Toxin Types A and B Policy (A57185) - R4 - Effective October 01, 2019 Jan 26, 2023
Billing and Coding: JW Modifier Billing Guidelines (A53024) - R5 - Effective January 10, 2023 Jan 23, 2023
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58973) - R1 - Effective January 01, 2023 Jan 18, 2023
Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (A57421) - R8 - Effective January 01, 2023 Jan 18, 2023
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R9 - Effective January 01, 2023 Jan 18, 2023
Billing and Coding: MolDX: myPap (A55292) - R4 - Effective January 1, 2023 Jan 12, 2023
Billing and Coding: MolDX: SMPD1 Genetic Testing (A55627) - R5 - Effective January 01, 2023 Jan 12, 2023
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R2 - Effective October 1, 2022 Jan 11, 2023
Billing and Coding: MolDX: Pharmacogenomics (A57384) - R7 - Effective December 07, 2022 Jan 11, 2023
Billing and Coding: COMPLEX DRUG Administration Coding (A58532) - R11 - Effective January 01, 2023 Dec 29, 2022
Billing and Coding: Lab: Controlled Substance Monitoring and Drugs of Abuse Testing (A55001) - R15 - Effective October 1, 2022 Dec 29, 2022
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) - R11 - Effective January 1, 2023 Dec 29, 2022
Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM) - (A58133) - R2 - Effective January 1, 2023 Dec 23, 2022
Billing and Coding: Implantable Automatic Defibrillators - (A56340) - R5 - Effective January 1, 2023 Dec 23, 2022
Billing and Coding: Treatment of Varicose Veins of the Lower Extremities - (A57706) - R1 - Effective January 1, 2023 Dec 23, 2022
Billing and Coding: Billing Medicare for the SphenoCath® and Other Similar Devices (A55584) - R5 - Effective January 1, 2023 Dec 22, 2022
Billing and Coding: Botulinum Toxin Types A and B Policy (A57185) - R3 - Effective January 1, 2023 Dec 22, 2022
Billing and Coding: Peripheral Nerve Stimulation (A55530) - R3 - Effective January 1, 2023 Dec 22, 2022
Billing and Coding: Tomosynthesis-Guided Breast Biopsy (A57848) - R1 - Effective January 1, 2023 Dec 22, 2022
Billing and Coding: Topical HBO and Physician Related Services Billing and Coding Guidelines (A56025) - R2 - Effective January 1, 2023 Dec 22, 2022
Billing and Coding: Immune Globulin Intravenous (IVIg) (A57187) - R5 - October 01, 2022 Dec 16, 2022
MolDX: Plasma-Based Genomic Profiling in Solid Tumors L39230 Final LCD - Effective December 26, 2022 Nov 14, 2022
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58973) Final Billing and Coding Article - Effective December 26, 2022 Nov 14, 2022
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R6 - Effective October 1, 2022 Nov 14, 2022
Billing and Coding: MolDX: ThermoFisher Oncomine Dx Target Test for Non-Small Cell Lung Cancer (A55881) Retirement - Effective October 27, 2022 Nov 14, 2022
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R6 - Effective October 1, 2022 Nov 14, 2022
Billing and Coding: Plastic Surgery (A57221) - R5 - Effective October 1, 2022 Nov 03, 2022
Billing and Coding: Lab: Controlled Substance Monitoring and Drugs of Abuse Testing (A55001) - R15 - Effective January 01, 2022 Nov 03, 2022
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R4 - Effective October 1, 2022 Oct 20, 2022
Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57901) - R2 - Effective October 1, 2022, and July 1, 2022 Oct 20, 2022